Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07794852
NA

Dural Sac Area-Guided Spinal Anesthesia Dosing for TURP

Sponsor: Istanbul University

View on ClinicalTrials.gov

Summary

This randomized controlled study will evaluate whether individualizing the dose of spinal anesthesia according to the ultrasound-derived dural sac cross-sectional area (DSCSA) can improve hemodynamic stability in patients undergoing transurethral resection of the prostate (TURP). Participants aged 40 years or older will be randomly assigned to one of two groups. In the individualized-dose group, the anteroposterior diameter of the dural sac will be measured by ultrasound at the L3-L4 level, and DSCSA will be calculated from this measurement. The dose of intrathecal bupivacaine will then be individualized according to the calculated DSCSA. In the control group, participants will receive a fixed dose of intrathecal bupivacaine. Both groups will also receive intrathecal fentanyl. The main outcome is the incidence of intraoperative hypotension. The study will also evaluate the number of hypotensive episodes, minimum mean arterial pressure, vasopressor and atropine requirements, sensory and motor block characteristics, respiratory monitoring parameters, cerebral oxygenation, and adverse events. The study aims to determine whether a DSCSA-guided dosing strategy can reduce excessive spinal block and improve hemodynamic stability while maintaining effective spinal anesthesia.

Official title: Clinical Effects of Individualized Spinal Anesthesia Dosing Based on Ultrasound-Measured Dural Sac Cross-Sectional Area in Patients Undergoing Transurethral Resection of the Prostate: A Prospective, Randomized Controlled Trial

Key Details

Gender

MALE

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-08-24

Completion Date

2026-12-10

Last Updated

2026-08-31

Healthy Volunteers

No

Interventions

PROCEDURE

DSCSA-Guided Individualized Spinal Anesthesia Dosing

The dural sac cross-sectional area (DSCSA) is calculated from the ultrasound-measured anteroposterior dural sac diameter at the L3-L4 level. The intrathecal bupivacaine dose is individualized according to DSCSA.

DRUG

Bupivacaine

Hyperbaric bupivacaine is administered intrathecally in both study groups. In the DSCSA-guided group, the dose is individualized according to DSCSA, using 150 mm² as the reference corresponding to 10 mg, with a permitted dose range of 6 to 12.5 mg. In the fixed-dose group, 10 mg (2 mL of 0.5% bupivacaine) is administered.

DRUG

Fentanyl (FEN)

Fentanyl 25 micrograms is administered intrathecally together with bupivacaine in both study groups.

Locations (1)

Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine

Istanbul, Turkey (Türkiye)